BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,610.00
+55.00 (1.21%)
At close: Nov 12, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 465.21 billion as of November 12, 2026. It is the 16,936th most valuable company in the world and the 458th biggest in South Korea. Its market cap has decreased by 18.33% in one year.
Market Cap
465.21B
Enterprise Value
100.15B
Revenue
126.41B
Global Rank
Country Rank
#458 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 465.21B, a decrease of -57.12%. That is a compound annual growth rate of -19.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 465.21B | -16.09% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SD Biosensor | 852.89B |
| SEERS | 556.77B |
| InBody Co.,Ltd | 544.54B |
| i-SENS | 386.49B |
| T&L Co., Ltd. | 379.19B |
| Samyang Biopharm | 325.32B |
| WON TECH | 317.63B |
| ToolGen | 298.54B |